Hikma Labs Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Intermittent Claudication
First Posted Date
2008-01-28
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
32
Registration Number
NCT00602173
Locations
๐Ÿ‡บ๐Ÿ‡ธ

CEDRA Clinical Research, LLC, Austin, Texas, United States

Bioequivalency Study of 450 mg Lithium Carbonate Under Fed Conditions

Not Applicable
Completed
Conditions
Bipolar Disorder
First Posted Date
2008-01-28
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
30
Registration Number
NCT00601575
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Arkansas Research, Little Rock, Arkansas, United States

Bioequivalency Study of Zolpidem Tartrate Under Fed Conditions

Not Applicable
Completed
Conditions
Insomnia
First Posted Date
2008-01-28
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
30
Registration Number
NCT00602719
Locations
๐Ÿ‡บ๐Ÿ‡ธ

PRACS Institute, Ltd., Fargo, North Dakota, United States

Bioequivalency Study of Torsemide Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Edema
First Posted Date
2008-01-28
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
28
Registration Number
NCT00602615
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Bio-Kinetic Clinical Applications, Inc., Springfield, Missouri, United States

Bioequivalency Study of 450 mg Lithium Carbonate Under Fasting Conditions

Not Applicable
Completed
Conditions
Bipolar Disorder
First Posted Date
2008-01-28
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
30
Registration Number
NCT00602381
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Arkansas Research, Little Rock, Arkansas, United States

Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Intermittent Claudication
First Posted Date
2008-01-28
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
36
Registration Number
NCT00602407
Locations
๐Ÿ‡บ๐Ÿ‡ธ

CEDRA Clinical Research, LLC, Austin, Texas, United States

Bioequivalency Study of Clarithromycin Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Infection
First Posted Date
2008-01-28
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
28
Registration Number
NCT00602498
Locations
๐Ÿ‡บ๐Ÿ‡ธ

MDS Pharma Services, Phoenix, Arizona, United States

Bioequivalency Study of Sertraline Under Fasting Conditions

Not Applicable
Completed
Conditions
Depression
First Posted Date
2008-01-28
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
38
Registration Number
NCT00602849
Locations
๐Ÿ‡จ๐Ÿ‡ฆ

Anapharm Inc., Sainte-Fly, Quebec, Canada

Bioequivalency Study of Zidovudine Under Fasting Conditions

Not Applicable
Completed
Conditions
HIV Infections
First Posted Date
2008-01-28
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
52
Registration Number
NCT00602550
Locations
๐Ÿ‡บ๐Ÿ‡ธ

CEDRA Clinical Research, Austin, Texas, United States

Bioequivalency Study of Clarithromycin Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Infection
First Posted Date
2008-01-28
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
40
Registration Number
NCT00601315
Locations
๐Ÿ‡บ๐Ÿ‡ธ

MDS Pharma Services, Phoenix, Arizona, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy